Related Experiment Video
Updated: May 7, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Depletion of the 26S proteasome adaptor Ecm29 increases Toll-like receptor 3 signaling
Carlos Gorbea1, Martin Rechsteiner, Jesús G Vallejo
11Division of Cardiology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Abstract:
Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA and stimulates the innate immune response. We found that depletion of extracellular mutant 29 (Ecm29), an adaptor protein that binds to a subset of 26S proteasomes (Ecm proteasomes), increased the abundance of TLR3 in human embryonic kidney-293 and HeLa cells. Loss of Ecm29 also increased the amounts of LC3β and p62, two proteins that mediate autophagy. The absence of Ecm29 enhanced TLR3 signaling, which was characterized by the increased abundance of the adaptor protein and E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 3, increased phosphorylation and activation of effector kinases downstream of TLR3, increased nuclear localization of the transcription factor interferon regulatory factor 3, and the accumulation of signaling molecules at juxtanuclear recycling endosomes. We conclude that Ecm proteasomes play a previously uncharacterized role in mediating autophagy, trafficking of TLR3, and attenuation of TLR3-dependent signaling.
Insights
Depleting extracellular mutant 29 (Ecm29) enhances Toll-like receptor 3 (TLR3) signaling and autophagy. Ecm proteasomes regulate TLR3 trafficking and innate immunity, revealing a new role in immune response attenuation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Toll-like receptor 3 (TLR3) is crucial for recognizing viral double-stranded RNA and initiating innate immune responses.
- Extracellular mutant 29 (Ecm29) is an adaptor protein associated with a subset of 26S proteasomes, termed Ecm proteasomes.
Purpose of the Study:
- To investigate the role of Ecm29 and Ecm proteasomes in regulating TLR3 abundance, signaling, and autophagy.
- To elucidate the impact of Ecm proteasome function on innate immune pathways mediated by TLR3.
Main Methods:
- Utilized human embryonic kidney-293 and HeLa cells to study protein expression and localization.
- Assessed the effects of Ecm29 depletion on TLR3, LC3β, p62, tumor necrosis factor receptor-associated factor 3 (TRAF3), and interferon regulatory factor 3 (IRF3) levels.
- Analyzed TLR3 signaling pathway activation, including kinase phosphorylation and nuclear translocation of transcription factors.
Main Results:
- Depletion of Ecm29 led to increased abundance of TLR3, LC3β, and p62.
- Absence of Ecm29 enhanced TLR3 signaling, evidenced by increased TRAF3, enhanced kinase phosphorylation, and IRF3 nuclear localization.
- Signaling molecules accumulated at juxtanuclear recycling endosomes in Ecm29-depleted cells.
Conclusions:
- Ecm proteasomes play a novel role in mediating autophagy and regulating the trafficking of TLR3.
- Ecm proteasomes are involved in the attenuation of TLR3-dependent signaling pathways.
- These findings uncover a new regulatory mechanism for innate immune responses involving Ecm proteasomes and TLR3.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Tumor Microenvironment
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

